This month they had a few interesting articles on new MS research I thought I’d enclose.
A new study shows an overlooked source may be able to replace lost nerve insulation and provide a new way to treat multiple sclerosis. The discovery of mature myelin-producing cells’ capacity for repair opens new opportunities to slow or reverse the disease. That may call for new therapeutic approaches that rally the oligodendrocytes to reach out with new lifelines to damaged myelin sheaths.
The ins and outs of stem cell therapy
According to a new study, mapping of oligodendrocytes in the central nervous system of a mouse model of multiple sclerosis shows they might play a significant role in the development of the disease. The discovery may lead to new therapies targeted at other areas than just the immune system.
B cells are important in helping the immune system fight pathogens. However, in the case of multiple sclerosis they can damage nerve tissue. When particular control cells are missing, too many B cells accumulate in the meninges, resulting in inflammation of the central nervous system. Technical University of Munich researchers demonstrated the process using a mouse model of MS and patient samples.